Candice Z. Ulmer
Centers for Disease Control and Prevention (CDC)
As an advocate for STEM outreach and diversity/equity/inclusion (DEI) efforts, the current chair of the ASMS Diversity and Inclusion Committee, and the co-founder of the Coalition for Black Mass Spectrometrists, I strongly support the broadened goals for the ASMS BoD Member at Large for Membership position. In these roles and my other external committee positions within the diversity scope, I have facilitated listening sessions for the membership and ensured the integration of environmental justice into all aspects of environmental public health work (i.e., public health assessments, laboratory work, tool development, research, national surveys, etc.). If elected I will strive to  ensure that our mentorship/REU programs and current/future initiatives reflect the needs/make-up of the membership,  sculpt these data-driven initiatives and programs to increase member retention/participation, and  guarantee diversity, equity, and inclusivity within the society.
Candice Z. Ulmer, Ph.D., B.S. in Chemistry (College of Charleston, Charleston, SC); B.S. in Biochemistry (College of Charleston, Charleston, SC); Ph.D. in Chemistry (University of Florida, Gainesville, FL – direction of Drs. Richard A. Yost and Timothy Garrett); National Research Council Postdoctoral Fellowship (National Institute of Standards and Technology – direction of Dr. John Bowden). Dr. Ulmer is currently a Senior Service Fellow, Clinical Research Chemist, and Project Lead in the Clinical Chemistry Branch of the Centers for Disease Control and Prevention (CDC) in Atlanta, GA.
Dr. Ulmer’s responsibilities include the accurate measurement of chronic disease biomarkers through the development of mass spectrometric reference measurement procedures for small molecules and proteins, the assessment of routine clinical analytical methods in patient care, and the integration/translation of analytical approaches to predict health risks and disease progression. She works to plan and execute standardization programs to ensure that clinical measurements, no matter when and where they are received, are always accurate and reproducible. Her talents and contributions as an early-career mass spectrometrist with over 30 peer-reviewed articles, book chapters, and application notes, were recognized in the June 2018 issue of the JASMS “Faces of Mass Spectrometry”.
Apart from her numerous oral/poster presentations since the beginning of her ASMS membership in 2013, Dr. Ulmer has organized and chaired sessions on the application of mass spectrometry at several ASMS Conferences. She currently serves as the co-chair of the ASMS clinical chemistry interest group (2018 – present) and chair of the ASMS diversity & inclusion committee (2021 – present). Dr. Ulmer has previously served on the ASMS publication committee (2018 – 2020) and ASMS diversity & inclusion committee (2020 – present). Apart from her roles within ASMS, Dr. Ulmer assumes appointed/elected memberships in other scientific organizations that include the International Metabolomics Society (MetSoc), the Metabolomics Quality Assurance and Quality Control Consortium (mQACC), Metabolomics of North America (MANA), the International Lipidomics Society (ILS), and the American Chemical Society (ACS). In addition, Dr. Ulmer was nominated by the American Association of Clinical Chemistry (AACC) to serve on the newly-formed International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on Bone Metabolism.